Life-prolonging treatments for end-stage demented patients are costly and of questionable value. Because most elderly individuals have not made directives in advance, decisions concerning their health care are made by surrogates, usually close family members. Currently, there are no standard methods for educating these surrogates concerning health care options and assisting them in decision making. The Pilot will determine the impacts of a structured intervention with families, focusing on the decision-making process of surrogates, distress to caregivers/families, and several outcome measures (e.g., clinical course, survival, and use of health care resources). The sample consists of 97 patients of Cohort 1 with severe Alzheimer's disease (AD), who have been followed in our Alzheimer's Disease Research Center (ADRC) for the past ten years, and their caregivers. The neurological, cognitive, physical, and functional status of patients will be documented, and we will analyze the effects, over the previous six months, of five activities: hospitalization; use of antibiotics; artificial feeding and hydration; resuscitation; and the use of diagnostic tests. The impacts of interventions on the emotional health and decisions of caregivers will be elicited through the use of mailed questionnaires. Caregivers will be assigned randomly to an educational group or a control group. The forum of the educational group will be two sessions of counselling concerning the rationale for specific interventions; control caregivers will not participate in this process. Six months later, we will assess the efficacies of the sessions on several parameters that focus on decision making in health care and benefits/feedback for surrogates, caregivers, and patients. We believe the study of this relatively neglected area may help us to design more effective strategies for dealing with issues commonly encountered in this population of elderly individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-15
Application #
6234101
Study Section
Project Start
1997-07-15
Project End
1998-03-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
15
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Eftekharzadeh, Bahareh; Daigle, J Gavin; Kapinos, Larisa E et al. (2018) Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron 99:925-940.e7
Kaji, Seiji; Maki, Takakuni; Kinoshita, Hisanori et al. (2018) Pathological Endogenous ?-Synuclein Accumulation in Oligodendrocyte Precursor Cells Potentially Induces Inclusions in Multiple System Atrophy. Stem Cell Reports 10:356-365
Na, Chan Hyun; Barbhuiya, Mustafa A; Kim, Min-Sik et al. (2018) Discovery of noncanonical translation initiation sites through mass spectrometric analysis of protein N termini. Genome Res 28:25-36
Johnson, Erik C B; Dammer, Eric B; Duong, Duc M et al. (2018) Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener 13:52
Albert, Marilyn; Zhu, Yuxin; Moghekar, Abhay et al. (2018) Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years. Brain :
Oh, Esther S; Blennow, Kaj; Bigelow, George E et al. (2018) Abnormal CSF amyloid-?42 and tau levels in hip fracture patients without dementia. PLoS One 13:e0204695
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Ganguli, Mary; Albanese, Emiliano; Seshadri, Sudha et al. (2018) Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health. Alzheimer Dis Assoc Disord 32:1-9
Tsapkini, Kyrana; Webster, Kimberly T; Ficek, Bronte N et al. (2018) Electrical brain stimulation in different variants of primary progressive aphasia: A randomized clinical trial. Alzheimers Dement (N Y) 4:461-472
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739

Showing the most recent 10 out of 830 publications